(NASDAQ:TLX), SAN FRANCISCO, Jan. 05, 2026 (GLOBE NEWSWIRE) — National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Telix Pharmaceuticals Ltd. (NASDAQ: TLX) that the deadline to move the Court for appointment as lead plaintiff in the pending securities class action lawsuit is January 9, 2026. The lawsuit follows a […]

Formic AI introduces Boreal, an Explainable Language Model Built for Verifiable Enterprise Use Boreal restructures unstructured text into a verifiable knowledge graph, checks answers against source material, and records its reasoning for an auditable trail, pairing precision with an efficiency-minded design. GlobeNewswire January 05, 2026 TORONTO, Jan. 05, 2026 (GLOBE NEWSWIRE) — Formic AI today

Telix (TLX) 4-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures GlobeNewswire January 05, 2026 SAN FRANCISCO, Jan. 05, 2026 (GLOBE NEWSWIRE) — National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Telix

(NYSE:LRN), SAN FRANCISCO, Jan. 05, 2026 (GLOBE NEWSWIRE) — National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Stride, Inc. (NYSE: LRN) that the deadline to move the Court for appointment as lead plaintiff in the pending securities class action lawsuit is January 12, 2026. The firm urges investors who

LRN 1-WEEK DEADLINE ALERT: Stride (LRN) Investors Encouraged to Contact Hagens Berman, Securities Class Action Pending Over Alleged Undisclosed Operational Failures GlobeNewswire January 05, 2026 SAN FRANCISCO, Jan. 05, 2026 (GLOBE NEWSWIRE) — National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Stride, Inc. (NYSE: LRN) that the deadline to

Philadelphia, Pennsylvania–(Newsfile Corp. – January 5, 2026) – National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) (“Stride” or the “Company”) on behalf of investors who purchased Stride securities during the period of October 22, 2024 through October 28, 2025 (the “Class Period”).

(NASDAQ:PLRZ), Raanana, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) — Polyrizon Ltd. Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions today announced positive results from a new in-vitro pre-clinical study evaluating the allergen-blocking performance of its PL-14 Allergy Blocker formulation compared to hydroxypropyl methylcellulose (HPMC), an accepted and

Polyrizon Announces New Pre-Clinical Results: PL-14 Demonstrates Significant Allergen-Blocking Performance Compared to a Standard Comparator GlobeNewswire January 05, 2026 Raanana, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) — Polyrizon Ltd. Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions today announced positive results from a new in-vitro pre-clinical study

(NASDAQ:ODYS), Englewood, New Jersey, US, Jan. 05, 2026 (GLOBE NEWSWIRE) — Odysight.ai Inc. (NASDAQ:ODYS), a leader in AI-powered visual sensing and Predictive Maintenance (PdM) technologies, today announced that it had posted a CEO letter to shareholders on the Company's investor relations website at https://www.odysight.ai/. The CEO letter to shareholders is reproduced below. Dear Shareholders, As

(NasdaqGM:SOUN), SANTA CLARA, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) — SoundHound AI, Inc. (Nasdaq: SOUN), a global leader in voice and conversational AI, today announced that it's bringing the full power of its Amelia 7 agentic AI to vehicles, TVs, and smart devices – enabling a significantly expanded voice commerce marketplace, with AI agents that